# Bristol-Myers Squibb: what changed between 2025-11-09 and 2026-11-09 entity: /record/bristol-myers-squibb.md from: 2025-11-09 to: 2026-11-09 page: /record/bristol-myers-squibb/diff?from=2025-11-09&to=2026-11-09 json: /v1/entities/bristol-myers-squibb/diff?from=2025-11-09&to=2026-11-09 Between 2025-11-09 and 2026-11-09, Bristol-Myers Squibb's record changed in 17 facts: 3 replaced (net income -$8.95 billion → $7.05 billion; research and development $11.16 billion → $9.95 billion; revenue $48.3 billion → $48.19 billion), 7 added, 7 ended; 15 unchanged. State as of 2025-11-09: /record/bristol-myers-squibb.md?as_of=2025-11-09 · as of 2026-11-09: /record/bristol-myers-squibb.md?as_of=2026-11-09. Format: subject | predicate | value | valid range | confidence | status | claim. Posts and Hugging Face repos are left out (0 held on 2025-11-09, 0 on 2026-11-09). ## Replaced (3) The same fact with a different value: the claim that held on the earlier day, then the one that holds on the later day. - net income: -$8.95 billion → $7.05 billion - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | -8,948,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_52D44073C808](/claim/clm_52D44073C808.md) | [clm_93176D9F8458](/claim/clm_93176D9F8458.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 7,054,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_52D44073C808](/claim/clm_52D44073C808.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm - research and development: $11.16 billion → $9.95 billion - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 11,159,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_1D1D9926921B](/claim/clm_1D1D9926921B.md) | [clm_CC290D20ACB7](/claim/clm_CC290D20ACB7.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 9,951,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_1D1D9926921B](/claim/clm_1D1D9926921B.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm - revenue: $48.3 billion → $48.19 billion - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 48,300,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_BB9F55DFC7A5](/claim/clm_BB9F55DFC7A5.md) | [clm_78596CC18E60](/claim/clm_78596CC18E60.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 48,194,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_BB9F55DFC7A5](/claim/clm_BB9F55DFC7A5.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm ## Added (7) Held on 2026-11-09, not on 2025-11-09. - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 9,574,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_D7A2CC833948](/claim/clm_D7A2CC833948.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 2,162,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_247D46C4A3C2](/claim/clm_247D46C4A3C2.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,365,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_F9CEFB4CA8DE](/claim/clm_F9CEFB4CA8DE.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 13,069,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_41E4C7C8DCE2](/claim/clm_41E4C7C8DCE2.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,044,085,831 shares | valid 2026-10-21 to present | conf 0.95 | valid | [clm_434253DF3386](/claim/clm_434253DF3386.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 88,772,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_ABE255E98610](/claim/clm_ABE255E98610.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 23,404,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_724BB1A9B7DC](/claim/clm_724BB1A9B7DC.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm ## Ended (7) Held on 2025-11-09, not on 2026-11-09, and not replaced by another value. - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 15,726,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_71B9DA11CD2A](/claim/clm_71B9DA11CD2A.md) | [clm_8F913554EE54](/claim/clm_8F913554EE54.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 2,201,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_59B16D5CFE58](/claim/clm_59B16D5CFE58.md) | [clm_B6387AF1FB92](/claim/clm_B6387AF1FB92.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,528,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_66E70FD09231](/claim/clm_66E70FD09231.md) | [clm_F60212FAE72C](/claim/clm_F60212FAE72C.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 12,222,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_3BBDC1786FBC](/claim/clm_3BBDC1786FBC.md) | [clm_BB784B853512](/claim/clm_BB784B853512.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,035,753,027 shares | valid 2025-10-23 to 2026-02-04 | conf 0.95 | superseded | superseded_by [clm_7BDDFBA6A82F](/claim/clm_7BDDFBA6A82F.md) | [clm_5DF65CC84443](/claim/clm_5DF65CC84443.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 96,889,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_16735433DCF9](/claim/clm_16735433DCF9.md) | [clm_B080F3CCA436](/claim/clm_B080F3CCA436.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 18,552,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_D808E9CABB64](/claim/clm_D808E9CABB64.md) | [clm_3AA608585C53](/claim/clm_3AA608585C53.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm ## Unchanged 15 claims held on both days: ceo 1, cfo 1, chair 1, cik 1, fiscal_year_end 1, headquarters 1, listed_on 1, quarterly_operating_income 1, registrant_name 1, sic_industry 1, state_of_incorporation 1, ticker 2, website 1, x_username 1. ## Get this data - JSON: /v1/entities/bristol-myers-squibb/diff?from=2025-11-09&to=2026-11-09 - MCP: entity_diff(entity: "bristol-myers-squibb", from: "2025-11-09", to: "2026-11-09") - Entity twin: /record/bristol-myers-squibb.md · timeline: /timelines/bristol-myers-squibb.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.